Cited by 377Parkinson's Disease Mechanisms and TreatmentsStatistical Methods in EpidemiologyDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Risk tables for parkinsonism and Parkinson’s disease

Elbaz, Alexis, Bower, James H, Maraganore, Demetrius M, McDonnell, Shannon K, Peterson, Brett J, Ahlskog, J.Eric, Schaid, Daniel J, Rocca, Walter A·2002·Journal of Clinical Epidemiology

DOI 10.1016/s0895-4356(01)00425-5

Open this paper in CoChat — free account

Abstract

We applied the incidence rates of parkinsonism and Parkinson's disease (PD) from Olmsted County, MN (1976-1990) to a hypothetical cohort undergoing the mortality rates observed in Minnesota, and computed the lifetime risk and the remaining lifetime risk of developing parkinsonism and PD. These risks were compared to cumulative incidences that do not take competing risks of death into account. The lifetime risk of developing parkinsonism from birth was 4.4% for men and 3.7% for women (ratio = 1.2). The corresponding risk of developing PD was 2.0% for men and 1.3% for women (ratio = 1.5). Because of the opposite effect of higher incidence and higher mortality rates in men, the lifetime risks were only slightly higher in men than in women. Lifetime cumulative incidences were consistently higher than lifetime risks; this difference was more pronounced in men and in older subjects. Lifetime risk estimates are useful in clinical practice, epidemiologic research, and public health.

Integrity signals

Registry

Crossref · 10.1016/s0895-4356(01)00425-5

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

History of the Rochester Epidemiology Project
Melton, L. J. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.266 · Cited by 1,443
Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.
de Rijk, M. C., Tzourio, C., Breteler, M. M., Dartigues, J. F., Amaducci, L., Lopez-Pousa, S., Manubens-Bertran, J. M., Alperovitch, A., & Rocca, W. A. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.1.10 · Cited by 833
The Patient Record in Epidemiology
Kurland, L. T., & Molgaard, C. A. (1981) · Scientific American · doi:10.1038/scientificamerican1081-54 · Cited by 780
The Lifetime Risk of Developing Breast Cancer
Feuer, E. J., Wun, L., Boring, C. C., Flanders, W. D., Timmel, M. J., & Tong, T. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.11.892 · Cited by 640
Parkinson’s disease and parkinsonism in a longitudinal study: Two-fold higher incidence in men
Baldereschi, M., Di Carlo, A., Rocca, W. A., Vanni, P., Maggi, S., Perissinotto, E., Grigoletto, F., Amaducci, L., & Inzitari, D. (2000) · Neurology · doi:10.1212/wnl.55.9.1358 · Cited by 526
Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990
Bower, J. H., Maraganore, D. M., McDonnell, S. K., & Rocca, W. A. (1999) · Neurology · doi:10.1212/wnl.52.6.1214 · Cited by 509
Lifetime risk of dementia and Alzheimer's disease: The impact of mortality on risk estimates in the Framingham Study
Seshadri, S., Wolf, P. A., Beiser, A., Au, R., McNulty, K., White, R., & D'Agostino, R. B. (1997) · Neurology · doi:10.1212/wnl.49.6.1498 · Cited by 489
Incidence and Risk of Dementia: The Rotterdam study
Ott, A., Breteler, M. M. B., Harskamp, F. V., Stijnen, T., & Hofman, A. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009489 · Cited by 455
The Frequency of Idiopathic Parkinson's Disease by Age, Ethnic Group, and Sex in Northern Manhattan, 1988–1993
Mayeux, R. P., Marder, K. S., COTE, L. J., Denaro, J. E., Hemenegildo, N., Mejia‐Santana, H., Tang, M., Lantigua, R., Wilder, D., Gurland, B. J., et al. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117721 · Cited by 387
Risk of Parkinson's disease among first-degree relatives
Marder, K. S., Tang, M., Mejía, H., Alfaro, B., Cote, L. J., Louis, E. K. S., Groves, J. T., & Mayeux, R. P. (1996) · Neurology · doi:10.1212/wnl.47.1.155 · Cited by 248

Show all 21 references

Sorted by citations

Items 201–300 of 377

The Degenerative Dementias
Caselli, R. J., & Boeve, B. F. (2007) · Elsevier eBooks · doi:10.1016/b978-141603618-0.10033-5 · Cited by 16
The lifetime risk of surgery in England: a nationwide observational cohort study
Watson, S.-L., Fowler, A. J., Dias, P., Biccard, B. M., Wan, Y. I., Pearse, R. M., & Abbott, T. E. F. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.06.028 · Cited by 16
Protocol of a prospective study on the diagnostic value of transcranial duplex scanning of the substantia nigra in patients with parkinsonian symptoms
Vlaar, A. M. M., Bouwmans, A. E. P., van Kroonenburgh, M. J. P. G., Mess, W. H., Tromp, S. C., Wuisman, P. G., Kessels, A. G. H., Winogrodzka, A., & Weber, W. E. J. (2007) · BMC Neurology · doi:10.1186/1471-2377-7-28 · Cited by 15
Machine learning and deep learning approach to Parkinson’s disease detection: present state-of-the-art and a bibliometric review
Sabherwal, G., & Kaur, A. (2024) · Multimedia Tools and Applications · doi:10.1007/s11042-024-18398-3 · Cited by 15
Association between a body shape index and Parkinson's disease: A large cross-sectional study from NHANES
Huang, W., Xiao, Y., Zhang, L., & Hu, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26557 · Cited by 15
Microglia signaling in health and disease – Implications in sex-specific brain development and plasticity
Pramanik, S., Harini Devi, M., Chakrabarty, S., Paylar, B., Pradhan, A., Thaker, M., Ayyadhury, S., Manavalan, A., Olsson, P., Pramanik, G., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105834 · Cited by 18
Progressively disrupted somatodendritic morphology in dopamine neurons in a mouse Parkinson's model
Lynch, W. B., Tschumi, C. W., Sharpe, A. L., Branch, S. Y., Chen, C., Ge, G., Li, S., & Beckstead, M. J. (2018) · Movement Disorders · doi:10.1002/mds.27541 · Cited by 15
Sex and freezing of gait in Parkinson’s disease: a systematic review and meta-analysis
Tosserams, A., Mazaheri, M., Vart, P., Bloem, B. R., & Nonnekes, J. H. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10117-w · Cited by 15
SNAP25 Gene Polymorphisms Protect Against Parkinson’s Disease and Modulate Disease Severity in Patients
Agliardi, C., Guerini, F. R., Zanzottera, M., Riboldazzi, G., Zangaglia, R., Sturchio, A., Casali, C., Lorenzo, C. D., Minafra, B., Nemni, R., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1386-0 · Cited by 15
Linking Puberty and the Gut Microbiome to the Pathogenesis of Neurodegenerative Disorders
Esposito, P., & Ismail, N. (2022) · Microorganisms · doi:10.3390/microorganisms10112163 · Cited by 14
Oscillatory and non-oscillatory features of the magnetoencephalic sensorimotor rhythm in Parkinson’s disease
Vinding, M. C., Waldthaler, J., Eriksson, A., Manting, C. L., Ferreira, D., Ingvar, M., Svenningsson, P., & Lundqvist, D. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00669-3 · Cited by 29
Effects of glutathione S-transferase M1 and T1 deletions on Parkinson's disease risk among a North African population
Rebai, A., Chbili, C., Amor, S. B., Hassine, A., Ammou, S. B., & Saguem, S. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.03.013 · Cited by 14
Pharmacological manipulation of ataxia-telangiectasia kinase activity as a treatment for Parkinson’s disease
Shackelford, R. E., Manuszak, R. P., Heard, S. C., Link, C. J., & Wang, S. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.08.029 · Cited by 14
Changes in non-oscillatory features of the cortical sensorimotor rhythm in Parkinson's disease across agePreprint
Vinding, M. C., Eriksson, A., Manting, C. L., Waldthaler, J., Ferreira, D., Ingvar, M., Svenningsson, P., & Lundqvist, D. (2021) · medRxiv · doi:10.1101/2021.06.27.21259592 · Cited by 14
Acuity to Changes in Self-Generated Vocal Pitch in Parkinson's Disease
Abur, D., & Stepp, C. E. (2020) · Journal of Speech Language and Hearing Research · doi:10.1044/2020_jslhr-20-00003 · Cited by 13
Octogenarian parkinsonism – Clinicopathological observations
Rajput, A. H., & Rajput, E. F. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.01.009 · Cited by 13
Stabilization of Human Tyrosine Hydroxylase in Maltodextrin Nanoparticles for Delivery to Neuronal Cells and Tissue
Bezem, M. T., Johannessen, F. G., Jung‐KC, K., Gundersen, E. T., Jorge‐Finnigan, A., Ying, M., Betbeder, D., Herfindal, L., & Martı́nez, A. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00807 · Cited by 14
Parkinson's disease in diphenyl-exposed workers—A causal association?
Wastensson, G., Hagberg, S., Andersson, E., Johnels, B., & Barregård, L. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.06.010 · Cited by 13
A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson’s disease
Gallagher, C. L., Johnson, S. C., Bendlin, B. B., Chung, M. K., Holden, J. E., Oakes, T. R., Brooks, B. R., Konopacki, R. A., Dogan, S., Abbs, J. H., et al. (2011) · Brain Imaging and Behavior · doi:10.1007/s11682-011-9124-5 · Cited by 13
Skewed X-chromosome inactivation and XIST locus methylation levels do not contribute to the lower prevalence of Parkinson's disease in females
Sharma, A., Kaut, O., Pavlova, A. V., Fröhlich, H., Ahmad, A., Schmitt, I., El‐Maarri, O., Oldenburg, J., & Wüllner, U. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.021 · Cited by 12
Sex differences in dopamine integrity and brain structure among healthy older adults: Relationships to episodic memory
Karalija, N., Papenberg, G., Wåhlin, A., Johansson, J. J., Andersson, M., Axelsson, J., Riklund, K., Lindenberger, U., Nyberg, L. H., & Bäckman, L. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.022 · Cited by 14
The effect of Parkinson’s disease on total knee arthroplasty: a systematic review and meta-analysis
Yoon, J.-R., Yoon, T. H., & Lee, S. (2023) · Knee Surgery and Related Research · doi:10.1186/s43019-023-00179-1 · Cited by 12
Evaluation of Short-Term Cepstral Based Features for Detection of Parkinson’s Disease Severity Levels through Speech signals
Oung, Q. W., Basah, S. N., Muthusamy, H., Vijean, V., & Lee, H. L. (2018) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/318/1/012039 · Cited by 11
Conference Report: Advancing the Science of Developmental Neurotoxicity (DNT): Testing for Better Safety Evaluation.
Bal‐Price, A., Coecke, S., Costa, L. G., Crofton, K. M., Fritsche, E., Goldberg, A. M., Grandjean, P., Lein, P. J., Li, A., Lucchini, R. G., et al. (2012) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 11
The Link Between Lysosomal Storage Disorders and More Common Diseases
Beck, M. (2016) · Journal of Inborn Errors of Metabolism and Screening · doi:10.1177/2326409816682767 · Cited by 11
Prevention and Therapy of Neurodegenerative Disorders: Role of Nutritional Antioxidants
Matteo, V. D., Pierucci, M., Giovanni, G. D., & Esposito, E. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50168-x · Cited by 11
Smartphone Evaluation Heuristics for Older Adults
Calak, P. (2013) · The Atrium (University of Guelph) · Cited by 11
Disruption of α-Synuclein Proteostasis in the Striatum and Midbrain of Long-term Ovariectomized Female Mice
Zhou, L., Li, Y., Wang, M., Han, W., Chen, Q., Zhang, J., Sun, B., & Fan, Y. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.05.013 · Cited by 10
The role of RHOT1 and RHOT2 genetic variation on Parkinson disease risk and onset
Periñán, M. T., Gómez‐Garre, P., Blauwendraat, C., Mir, P., & Bandrés‐Ciga, S. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.07.003 · Cited by 10
RETRACTED: PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson’s Disease
Choi, Y. J., Kim, D. W., Shin, M. J., Yeo, H. J., Yeo, E. J., Lee, L. R., Song, Y., Kim, D., Han, K. H., Park, J., et al. (2021) · Molecules · doi:10.3390/molecules26113329 · Cited by 10
Retracted
Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson?s Disease
McArthur, S., & Gillies, G. E. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00082 · Cited by 10
Neuroanatomical correlates of polygenic risk for Parkinson’s DiseasePreprint
Abbasi, N., Tremblay, C., Rajimehr, R., Yu, E., Markello, R. D., Shafiei, G., Khatibi, N., study, T. E.-P., Jahanshad, N., Thompson, P. M., et al. (2022) · medRxiv · doi:10.1101/2022.01.17.22269262 · Cited by 9
The Role of Prenatal Microglial Activation and Its Sex Differences in the Development of Neuropsychiatric Disorders and Neurodegenerative Diseases
Lyamtsev, A. S., Sentyabreva, A. V., & Kosyreva, A. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189250 · Cited by 9
CCDC62 Variant rs12817488 Is Associated with the Risk of Parkinson's Disease in a Han Chinese Population
Liu, R., Zhou, L., Cheng, X., Sun, M.-X., Hu, Y., Chen, S., Zhang, X., & Zhu, J. (2013) · European Neurology · doi:10.1159/000354333 · Cited by 10
Meta-analyses of seven GIGYF2 polymorphisms with Parkinson’s disease
Dai, D., Wang, Y., Zhou, X., TAO, J., Jiang, D., Zhou, H., Jiang, Y., Pan, G., Ru, P., Ji, H., et al. (2014) · Biomedical Reports · doi:10.3892/br.2014.324 · Cited by 9
Inhibition of p38 pathway-dependent MPTP-induced dopaminergic neurodegeneration in estrogen receptor alpha knockout mice
Hwang, C. J., Choi, D., Jung, Y. Y., Lee, Y.-J., Yun, J. S., Oh, K., Han, S., Oh, S., Park, M. H., & Hong, J. T. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2016.01.011 · Cited by 9
Effets à long terme des produits phytosanitaires : le point sur les données épidémiologiques récentes
Testud, F., Grillet, J., & Nisse, C. (2007) · Archives des maladies professionnelles et de médecine du travail/Archives des maladies professionnelles et de l'environnement · doi:10.1016/s1775-8785(07)73890-0 · Cited by 9
Neurological and neuropsychological features in Parkinsonian patients exposed to neurotoxic metals.
Lucchini, R. G., Albini, E., Benedetti, L., Zoni, S., Caruso, A., Nan, E., Pasqualetti, P., Pm, R., Binetti, G. G., Benussi, L., et al. (2007) · PubMed · Cited by 9
Relationship between endocrine disruptors and neurodegenerative diseases: Systematic review and meta-analysis
Wang, C., Xu, J., Pan, K., Xu, Y., & Yu, J. (2025) · iScience · doi:10.1016/j.isci.2025.112779 · Cited by 8
Related cellular signaling and consequent pathophysiological outcomes of ubiquitin specific protease 24
Xiaoyang, S., Xia, B., Gao, X., Liu, X., Lv, H., Wang, S., Xiao, Q., & Luo, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122512 · Cited by 8
Should Exercise Be Prescribed Differently Between Women and Men? An Emphasis on Women Diagnosed With Parkinson's Disease
Rigby, B. R., & Davis, R. W. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01040 · Cited by 8
Can sex influence the neurocognition of language? Evidence from Parkinson's disease
Reifegerste, J., Estabrooke, I. V., Russell, L. E., Veríssimo, J., Johari, K., Wilmarth, B., Pagán, F., Moussa, C., & Ullman, M. T. (2020) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2020.107633 · Cited by 10
Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson’s Disease “Off” Episodes
Berger, A. A., Winnick, A. A., Izygon, J. J., Jacob, B. M., Kaye, J. S., Kaye, R. J., Neuchat, E. E., Kaye, A. M., Alpaugh, E. S., Cornett, E. M., et al. (2022) · Health Psychology Research · doi:10.52965/001c.36074 · Cited by 10
Blood α-synuclein in agricultural pesticide handlers in central Washington State
Nielsen, S. S., Checkoway, H., Zhang, J., Hofmann, J. N., Keifer, M., Paulsen, M., Farin, F. M., Cook, T. J., & Simpson, C. D. (2014) · Environmental Research · doi:10.1016/j.envres.2014.10.014 · Cited by 8
Current Medication Trendsand Global Impact on Neurodegenerative Disorders
Maurya, H., & Kumar, S. (2018) · Journal of Pharmaceutics & Pharmacology · doi:10.13188/2327-204x.1000024 · Cited by 8
Can amantadine therapy delay the onset of dementia in Parkinson's disease?
Rajput, A. H. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0322 · Cited by 8
Incidence of Parkinson’s disease in Germany based on prevalence data from 70 million patients of the statutory health insurance
Wattenbach, C., Ellrichmann, G., Feinkohl, I., Voß, S., & Brinks, R. (2024) · BMC Neurology · doi:10.1186/s12883-024-03739-4 · Cited by 7
Maladie de Parkinson : une maladie à forte composante environnementale ?
Elbaz, A., & Moisan, F. (2010) · Revue Neurologique · doi:10.1016/j.neurol.2010.07.008 · Cited by 7
Dermatoses in parkinsonism: the importance of multidisciplinary follow-up
Antunes, I., Purim, K. S. M., Grande, L. L., Alberton, N. C., Navarro, T. F. R., & Winckler, T. C. D. (2019) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.65.6.791 · Cited by 7
An Expert System for Identification of Key Factors of Parkinson's Disease: B-TDS-PD
Boruah, A. N., Biswas, S. K., Bandyonadhyay, S., & Sarkar, S. (2020) · IEEE India Council International Subsections Conference (INDISCON) · doi:10.1109/indiscon50162.2020.00020 · Cited by 7
Parkinson Disease: from Pathophysiology to the Animal Models
Vazifekhah, S., & Karimzadeh, F. (2016) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.4.3.91 · Cited by 7
The association between HSD3B7 gene variant and Parkinson's disease in ethnic Chinese
Lu, Z., Wang, L., Sun, X., Li, J., Cheng, L., Li, N., & Peng, R. (2018) · Brain and Behavior · doi:10.1002/brb3.913 · Cited by 7
Etiology and pathogenesis of Parkinson disease
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00005-6 · Cited by 8
Alpha-synuclein knockout impairs melanoma development and alters DNA damage repair in the TG3 mouse model in a sex-dependent manner
Arnold, M. R., Chen, S., & Unni, V. K. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1554059 · Cited by 6
A Comprehensive Study of miRNAs in Parkinson’s Disease: Diagnostics and Therapeutic Approaches
Siddique, Y. H., & Owais, S. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220111152756 · Cited by 6
Dopamine Synthesis in the Nigrostriatal Dopaminergic System in Patients at Risk of Developing Parkinson’s Disease at the Prodromal Stage
Blokhin, V. E., Pavlova, E., Катунина, Е. А., Nodel, M. R., Катаева, Г. В., Moskalets, E. R., Pronina, T. S., & Ugrumov, M. V. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030875 · Cited by 6
Acoustic and Kinematic Predictors of Intelligibility and Articulatory Precision in Parkinson's Disease
Thompson, A. R., & Kim, Y. (2024) · Journal of Speech Language and Hearing Research · doi:10.1044/2024_jslhr-24-00153 · Cited by 6
Seniors with Parkinson's Disease: Initial Medical Treatment
Ahlskog, J. E. (2010) · Journal of Clinical Neurology · doi:10.3988/jcn.2010.6.4.159 · Cited by 6
Neuroprotective Effects of Rasagiline in Parkinson's Disease: A Regional Cerebral Blood Flow Study
Im, J. J., Jeong, H. S., Chung, Y., Park, J., Heo, Y., Oh, J. K., & Song, I. (2019) · Journal of Neuroimaging · doi:10.1111/jon.12661 · Cited by 6
Parkinson disease
PARK, N. H. (2012) · JAAPA · doi:10.1097/01720610-201205000-00017 · Cited by 6
Biologische Grundlagen von Geschlechtsunterschieden
Arnold, A. P. (2007) · Springer eBooks · doi:10.1007/978-3-540-71628-0_2 · Cited by 6
From beta‐blockers to Parkinson's disease in respect of essential tremor
Vogelnik, K., & Kojović, M. (2019) · Movement Disorders · doi:10.1002/mds.27586 · Cited by 6
Rare but relevant: Methamphetamine and Parkinson's disease
Lappin, J. (2024) · Addiction · doi:10.1111/add.16695 · Cited by 5
Sexual Dimorphism in Levodopa‐Induced Dyskinesia Following Parkinson's Disease: Uncharted Territory
Bentall, L. M., & Parr‐Brownlie, L. C. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70144 · Cited by 6
Expert System to Manage Parkinson Disease by Identifying Risk Factors: TD-Rules-PD
Boruah, A. N., Biswas, S. K., Bandyopadhyay, S., & Sarkar, S. (2020) · International Conference on Computational Performance Evaluation (ComPE) · doi:10.1109/compe49325.2020.9200075 · Cited by 5
Optical coherence tomography (OCT) findings in patients with Parkinson's disease presenting to Farshchian Hospital (Sina) in 2019 compared to the normal population
Eslami, F., Ghiasian, M., Mohamadrahimi, B., Jiriaee, N., & Eslami-Ghayour, A. (2024) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2024.104379 · Cited by 5
Using virtual environments to assess visual perception judgements in patients with Parkinson’s disease
Ou, Y., Lin, C., Fang, C.-W., & Liu, Y. (2018) · Transportation Research Part F Traffic Psychology and Behaviour · doi:10.1016/j.trf.2018.04.023 · Cited by 5
Vascular parkinsonism: analysis of seven cases
da Silva, É. G., Viana, M. A., & Quagliato, E. M. A. B. (2006) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2006000400005 · Cited by 5
Current concepts on the etiology and pathogenesis of Parkinson disease
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00005-6 · Cited by 5
Sex-Specific Imaging Biomarkers for Parkinson’s Disease Diagnosis: A Machine Learning Analysis
Yang, Y., Hu, L., Chen, Y., Gu, W., Xie, Y., & Nie, S. (2024) · Journal of Imaging Informatics in Medicine · doi:10.1007/s10278-024-01235-2 · Cited by 4
Presentation of a new gender dependent feature selection approach for diagnosis of Parkinson disease using speech signal processing
Azadi, H., Akbarzadeh-T, M.-R., Kobravi, H., Sarcheshmeh, A. N., Shahsavanpour, N., & Asgharzade, M. R. (2015) · International Congress on Technology, Communication and Knowledge · doi:10.1109/ictck.2015.7582698 · Cited by 4
Mitochondrial Serine Protease HTRA2 p.G399S in a Female with Di George Syndrome and Parkinson’s Disease
Gambardella, S., Ferese, R., Scala, S., Carboni, S., Biagioni, F., Emiliano, G., Zampatti, S., Modugno, N., Fabbiano, F., Fornai, F., et al. (2018) · Parkinson s Disease · doi:10.1155/2018/5651435 · Cited by 4
Antiparkinsonian activity of Tabebuia impetiginosa bark and biochemical analysis of dopamine in rat brain homogenates
Roy, S. P., Kadiri, S. K., Karkar, V. V., & Konijeti, S. R. (2022) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2022.02.007 · Cited by 4
Use of gastrointestinal prokinetics and the risk of parkinsonism: A population‐based case‐crossover study
Kim, E., Kim, S., & Suh, H. S. (2023) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5668 · Cited by 4
Sex-dependent neuronal effects of α-synuclein reveal that GABAergic transmission is neuroprotective of sleep-controlling neurons
dos Santos, A. B., Thaneshwaran, S., Ali, L. K., Leguizamón, C. R. R., Wang, Y., Kristensen, M. P., Langkilde, A. E., & Kohlmeier, K. A. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01105-4 · Cited by 4
Substantia nigra hyperechogenicity in Polish patients with Parkinson’s disease
Ambrosius, W., Michalak, S., Owecki, M. K., Łukasik, M., Florczak‐Wyspianska, J., & Kozubski, W. P. (2014) · Folia Morphologica · doi:10.5603/fm.2014.0042 · Cited by 4
Factors Influencing Self Care Performance in Patients with Parkinson's Disease
Sook, H. (2010) · The Korean Journal of Rehabilitation Nursing · Cited by 4
Longitudinal correlation of cerebrospinal fluid GFAP and the progression of cognition decline in different clinical subtypes of Parkinson's disease
Liu, Y., Wang, J., Ning, F., Wang, G., & Xie, A. (2024) · Clinical and Translational Science · doi:10.1111/cts.70111 · Cited by 3
Demographic and Clinical Characteristics in Different Motor Subtypes of Parkinson’s Disease: How Well Do the Findings Fit Within the Framework of Existing Hypotheses?
Petrijan, T., & Menih, M. (2025) · Neurology International · doi:10.3390/neurolint17040051 · Cited by 3
Co-occurrence of parkinsonism and dementia in clinical practice
Liepelt‐Scarfone, I., Jamour, M., & Maetzler, W. (2012) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-011-0261-7 · Cited by 3
Association of four GSTs gene polymorphisms with Parkinson disease: A meta-analysis
Dai, D., Wang, Y., Wang, L., Li, J., Zhou, H., Ma, Q., Zhou, X., Pan, J., Pan, G., Chen, C., et al. (2014) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2014.52014 · Cited by 3
Lived Experiences of Elderly Living Alone with Parkinson Disease
Kim, Y. S., Kim, H.-K., & Lee, Y.-S. (2018) · Korean Journal of Adult Nursing · doi:10.7475/kjan.2018.30.4.394 · Cited by 3
Lower prevalence of metabolic syndrome and its components in the prediagnostic phase of Parkinson’s disease
Avisar, H., Greenbaum, U., Djaldetti, R., & Lerner, B. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01003-1 · Cited by 2
Involvement of nitric oxide in Parkinson's disease: Emphasis on sex difference in prevalence
Taşkıran, D., Nazlıel, B., İrkeç, C., Kutay, F., & Pöğün, Ş. (2003) · Neuroscience Research Communications · doi:10.1002/nrc.10068 · Cited by 2
Environmental Exposures and Risks for Parkinson’s Disease
Checkoway, H., Nielsen, S. S., & Racette, B. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800228-5.00012-1 · Cited by 2
Role of Nutritional Antioxidants in the Prevention and Treatment of Neurodegenerative Disorders
Esposito, E. (2006) · Nutrition and disease prevention · doi:10.1201/9781420019131.ch5 · Cited by 2
Deep Parkinson Disease Diagnosis: Stacked Auto-encoder
Shareef, E. A., & Ozsahin, D. U. (2018) · Advances in intelligent systems and computing · doi:10.1007/978-3-030-04164-9_76 · Cited by 2
Diagnóstico de síndromes parkinsonianas em uma clínica brasileira de distúrbios do movimento
Silva, E. G. S. E. G. S. E. G., Viana, M. A., & Quagliato, E. M. A. B. (2019) · Revista Neurociências · doi:10.34024/rnc.2005.v13.8789 · Cited by 2
Searching for a relationship between manganese and welding and Parkinson's disease
Brenner, S. R. (2006) · Neurology · doi:10.1212/01.wnl.0000209200.33974.b4 · Cited by 2
Triphenyltin inhibition of the proteasome activity and its influence on substrate protein levels in nerve cells
Chen, X., Shi, G., Zhong, G., Chen, J., Lin, S., & Sun, Q. Y. (2010) · Chinese Science Bulletin · doi:10.1007/s11434-009-0678-1 · Cited by 2
Race and Ethnic Background in Parkinson’s Disease: A Literature Review and Risk Factor AnalysisPreprint
Siddiqi, S., Li, J., Ortiz, Z., Lawrence, K., Redmond, M. L., Tomlinson, J. J., Schlossmacher, M. G., & Salmaso, N. (2023) · Research Square · doi:10.21203/rs.3.rs-3389274/v1 · Cited by 2
Tiempos de activación muscular frente a una desestabilización en pacientes con enfermedad de Parkinson en etapas iniciales
Moya-Jofre, C., Valencia, O., Barrera, M., Valenzuela, O. A., & Guzmán‐Venegas, R. (2022) · Rehabilitación · doi:10.1016/j.rh.2022.07.004 · Cited by 1
Recent advances in the role of rehabilitative therapies for Parkinson’s disease: A literature review
Sohail, B., Iqbal, M. A., Razzaq, A., Nafe, A. W., & Malik, R. (2023) · Journal of Mind and Medical Sciences · doi:10.22543/2392-7674.1365 · Cited by 1
Reproductive life factors and estro-progestin exposure in women with early-onset Parkinson's disease compared to late-onset disease and controls: A retrospective cohort study
Patanè, G., Piat, C., Mullan, A. F., Kapelle, W., Ghoniem, K., Camerucci, E., Turcano, P., & Savica, R. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.107058 · Cited by 1
Exosomal Cargoes Derived from Neural Stem Cell: A New Strategy of Parkinson's Disease Treatment
Tarbali, S., Dadkhah, M., & Payandeh, Z. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05637-3 · Cited by 2
The IC-SNc neural circuit mediates prepulse inhibition deficits in MPTP-induced Parkinson’s disease male mice
Peng, X., Cui, C., Shi, Y., Li, T., Li, M., Yang, X., Lei, J., Yang, J., Yao, Y., Luo, G., et al. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01381-0 · Cited by 1
Parkinson’s Disease: Insights from the Laboratory and Clinical Therapeutics
Zhou, J.-Y., Yu, Y., Zhu, X.-L., Ng, C.-P., Lü, G., & Poo, W.-S. (2012) · InTech eBooks · doi:10.5772/33092 · Cited by 1
The Co‐Occurrence of Tricho‐Rhino‐Phalangeal Syndrome and Early‐Onset Levodopa‐Sensitive Parkinsonism
Hopfner, F., Caliebe, A., Deuschl, G., & Schneider, S. A. (2014) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12085 · Cited by 1
Gender‐related protection from or vulnerability to severe CNS diseases: Gonado‐structural and/or gonado‐activational? A meta‐analysis of relevant epidemiological studies
Braun, C. M. J., & Roberge, C. (2014) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2014.07.009 · Cited by 1
Effect of Low Frequency Bilateral Deep Brain Stimulation of the Subthalamic Nucleus on Balance and Gait in Parkinson Disease
Vallabhajosula, S. (2010) · University of Florida Digital Collections (University of Florida) · Cited by 1

Authors: Elbaz, A., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A.
Affiliations: Mayo Clinic (US)
Corresponding author: Rocca, Walter A
ORCID: Elbaz, Alexis
Bower, James H
Maraganore, Demetrius M
McDonnell, Shannon K
Ahlskog, J.Eric
Schaid, Daniel J
Rocca, Walter A
Venue: Journal of Clinical Epidemiology
Publisher: Elsevier BV
Published: 2002-01
Volume: 55
Issue: 1
Pages: 25-31
ISSN: 0895-4356 (ISSN-L)
DOI: 10.1016/s0895-4356(01)00425-5
OpenAlex: W2013713870
Cited by: 377
References: 21
Citations by year: 2026: 6 · 2025: 15 · 2024: 21 · 2023: 14 · 2022: 20 · 2021: 16 · 2020: 21 · 2019: 25 · 2018: 32 · 2017: 18 · 2016: 23 · 2015: 19 · 2014: 21 · 2013: 10 · 2012: 12
FWCI: 5.31
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Clinical Epidemiology (publishedVersion)
PubMed (publishedVersion)
Funders: Institut National de la Santé et de la Recherche Médicale
National Institutes of Health
National Institute of Neurological Disorders and Stroke (R01NS033978, NS33978)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR030582, AR30582)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Parkinson's disease, parkinsonism, lifetime risk, cumulative incidence, competing risk of death, incidence rates, mortality rates, sex differences, Olmsted County, Minnesota
MeSH terms: Adult, Aged, Female, Humans, Male, Middle Aged, Minnesota, Parkinson Disease, Risk Factors, Life Tables, Incidence, Age Distribution, Sex Distribution, Parkinsonian Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Risk tables for parkinsonism and Parkinson’s disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks